Innate Pharma SA
SWB:IDD
Innate Pharma SA
SWB:IDD
Price:
1.222
EUR
-1.77%
Market Closed
Market Cap:
€164.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
Innate Pharma SA
SWB:IDD
|
FR |
|
C
|
Country Garden Services Holdings Co Ltd
OTC:CTRGF
|
CN |
|
IPD Group Ltd
F:IS6
|
AU |
|
Innate Pharma SA
F:IDDA
|
FR |
|
N
|
NETGEAR Inc
SWB:NGJ
|
US |
|
R
|
Rockfire Resources PLC
F:P2P
|
UK |
Wall St Price Targets
IDD Price Targets Summary
Innate Pharma SA
Innate Pharma SA
Wall Street analysts forecast IDD stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for IDD is 4.33 EUR with a low forecast of 3.606 EUR and a high forecast of 5.166 EUR.
Lowest Forecast
Price Target
3.606
EUR
195% Upside
Average Forecast
Price Target
4.33
EUR
254% Upside
Highest Forecast
Price Target
5.166
EUR
323% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IDD's stock price target?
Price Target
4.33
EUR
4.33
EUR
According to Wall Street analysts, the average 1-year price target for IDD is 4.33 EUR with a low forecast of 3.606 EUR and a high forecast of 5.166 EUR.
What is the Revenue forecast for Innate Pharma SA?
Projected CAGR
92%
92%
Over the last 14 years, the compound annual growth rate for Revenue has been -7%. The projected CAGR for the next 7 years is 92%.
